Allianz Asset Management’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding BLUE
CS
Allianz Asset Management's BLUE Position: Q4 2020 in Review
Allianz Asset Management sold out of bluebird bio (BLUE) in Q4 2020, closing a stake of 807 shares — an estimated $564K sold.
Allianz Asset Management first reported a position in BLUE in Q4 2014 and held it in 24 quarters. The position peaked at $15.5M in Q2 2018. 262 funds tracked by Wall St. Rank hold BLUE as of Q4 2020.
- Allianz Asset Management reported no remaining bluebird bio position as of Q4 2020 after selling out during the quarter.
- Allianz Asset Management sold 807 bluebird bio shares in Q4 2020, an estimated $564K.
- Allianz Asset Management first reported a position in bluebird bio in Q4 2014 and held it in 24 quarters.
- Allianz Asset Management's bluebird bio position peaked at $15.5M in Q2 2018.
- 262 funds tracked by Wall St. Rank held bluebird bio as of Q4 2020.
Based on Allianz Asset Management's 13F filing for Q4 2020, filed 16 Feb 2021.